Effects of Preoperative Glycyrrhizin Infusion for the Prevention of Venous Thrombosis on the Tissue Expression of Antithrombin in a Rat Model
-
- Nakata Nobuaki
- Department of Orthopedic Surgery, Osaka Medical Prison Hospital, Sakai, Osaka, Japan
-
- Kira Yukimi
- Department of Central Laboratory, Osaka City University Medical School, Sakai, Osaka, Japan
この論文をさがす
抄録
Objective: Using a thrombus model prepared by ligation of the inferior vena cava (IVC), the influences of the glycoside, glycyrrhizin, on plasma antithrombin levels and antithrombin mRNA expression levels in the liver and IVC with the inhibition of venous thrombosis were investigated.Materials and Methods: The rat IVC was exposed and ligated for 24 h immediately after the intravenous administration of 300 mg/kg glycyrrhizin. Among antithrombotic drugs, the Xa inhibitor, fondaparinux sodium, was used as a control drug.Results: The mean thrombus weight was significantly smaller in the glycyrrhizin-treated group (18.3 mg) than in the saline-treated group (34.3 mg). In contrast, the inhibition of thrombosis was not observed in the fondaparinux-treated group. Antithrombin mRNA expression levels in the liver were significantly higher in the ligated groups than in the baseline control group. The mean plasma antithrombin level was significantly lower in the glycyrrhizin group (96.6%) than in the saline group (114.4%), but was not significantly different from that in the baseline control group (102.4%).Conclusion: The pretreatment with glycyrrhizin inhibited venous thrombosis, and antithrombin mRNA expression levels in the liver and IVC as well as plasma antithrombin levels were significantly lower than those in the saline group.
収録刊行物
-
- Annals of Vascular Diseases
-
Annals of Vascular Diseases 9 (2), 95-101, 2016
Annals of Vascular Diseases 編集委員会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001205275722496
-
- NII論文ID
- 130005159009
-
- ISSN
- 18816428
- 1881641X
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可